IKT
Inhibikase Therapeutics, Inc.
There isn't enough reported data to score IKT yet.
IKT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
IKT's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
IKT PE Valuation
IKT has no meaningful PE right now: it lost money over the past year.
IKT Forward outlook
There aren't enough analyst estimates for IKT to show an outlook.
IKT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$2.68 | +$1.33 |
| Q2 2024 | -$2.89 | +$1.34 |
| Q1 2024 | -$3.34 | +$0.86 |
| Q4 2023 | -$3.57 | +$0.75 |
| Q3 2023 | -$4.01 | +$0.13 |
| Q2 2023 | -$4.23 | -$0.09 |
| Q1 2023 | -$4.20 | +$0.18 |
| Q4 2022 | -$4.32 | +$0.54 |
IKT is still losing money, but far less than before: $0.41 per share over the past year, against $4.86 at its worst in late 2021.
IKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $1 | -100% |
| Q3 2023 | $79.6K | +991% |
| Q2 2023 | $116.4K | +1677% |
| Q1 2023 | $64.5K | +40% |
| Q4 2022 | $63.6K | +3170% |
| Q3 2022 | $7.3K | -98% |
| Q2 2022 | $6.6K | -100% |
| Q1 2022 | $46K | -97% |
IKT's revenue is shrinking: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2023 | -440356600% | -440349780 points |
| Q3 2023 | -5993% | +55906 points |
| Q2 2023 | -5328% | +65489 points |
| Q1 2023 | -7308% | +2774 points |
| Q4 2022 | -6820% | +252515 points |
| Q3 2022 | -61900% | -60538 points |
| Q2 2022 | -70817% | -70624 points |
| Q1 2022 | -10081% | -9895 points |
IKT's operating margin was −440356600% last quarter, down 440349780 points from the same quarter a year ago, near the bottom of its range since 2019.
IKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$17.4M | -$6.8M |
| Q2 2026 | -$12.4M | -$6.9M |
| Q1 2026 | -$12.1M | -$7.9M |
| Q4 2025 | -$7.5M | -$2.2M |
| Q3 2025 | -$10.6M | -$5.7M |
| Q1 2025 | -$4.1M | -$249.9K |
| Q4 2024 | -$5.3M | -$1.9M |
| Q3 2024 | -$4.9M | -$776K |
IKT has burned cash in almost every quarter: −$49M over the past year, against −$26M the year before.
IKT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +13% | +22.4M shares |
| 1 year | +119% | +107M shares |
| 3 years | +4195% | +192M shares |
| 5 years | +14158% | +196M shares |
| Available history | +14344% | +196M shares |
IKT has 197M diluted shares, up 119% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
IKT Net Leverage
IKT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.4 | Neutral |
| Stochastic | 6.5 | Oversold |
IKT's weekly RSI is 35 (neutral) and its Stochastic is 6 (oversold).
IKT PE vs Healthcare Sector
IKT has no meaningful PE right now: it lost money over the past year.
IKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.73 | 12% below |
| 20 week MA | $2.07 | 26% below |
| 50 week MA | $1.89 | 19% below |
| 100 week MA | $1.95 | 22% below |
| 200 week MA | $2.13 | 28% below |
IKT is in a downtrend: it's below all five of its weekly moving averages, and 28% below its 200-week average.
IKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $58.8 | $58.8 | 0% |
| 2021 | $58.8 | $9.42 | -84% |
| 2022 | $9.42 | $2.97 | -68% |
| 2023 | $2.97 | $1.27 | -57% |
| 2024 | $1.27 | $3.05 | +140% |
| 2025 | $3.05 | $2.00 | -34% |
| 2026 YTD | $2.00 | $1.53 | -24% |
IKT's yearly returns have swung widely, from +140% in 2024 to −84% in 2021. It's down 24% so far in 2026.